InvestorsHub Logo
Followers 0
Posts 102
Boards Moderated 0
Alias Born 04/16/2001

Re: pb35 post# 12816

Monday, 08/10/2015 11:14:09 AM

Monday, August 10, 2015 11:14:09 AM

Post# of 470911
I particularly liked this part of the PR:

"Companies that receive funding from MJFF have scientifically compelling plans that hold obvious potential to impact our understanding of Parkinson’s and ultimately the development of improved treatments for people with the disease. To that end, we look forward to the results of the ANAVEX 2-73 study.” -
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News